1
|
Glasner S, Wei AX, Ryan PC, Michero DN, Monico LB, Pielsticker PE, Horowitz LM. Implementing Suicide Risk Screening in a Virtual Addiction Clinic. Community Ment Health J 2024; 60:98-107. [PMID: 37688670 PMCID: PMC10799808 DOI: 10.1007/s10597-023-01181-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Accepted: 08/22/2023] [Indexed: 09/11/2023]
Abstract
The purpose of this study was to describe the feasibility of implementing suicide risk screening in a virtual addiction clinic. Suicide risk screening was implemented in a virtual addiction clinic serving individuals with substance use disorders (SUD) using a quality improvement framework. One-hundred percent (252/252) of eligible patients enrolled in the clinic were screened for suicide risk (44% female; M[SD] age = 45.0[11.0] years, range = 21-68 years). Nineteen patients (8%) screened positive for suicide risk. After screening, no patients required emergency suicide interventions (100% non-acute positive). Notably, 74% (14/19) of those who screened positive did so by endorsing at least one past suicide attempt with no recent ideation. Suicide risk screening in virtual addiction clinics yields important clinical information for high-risk SUD populations without overburdening workflow with emergency services. Given the high proportion of non-acute positive screens based on suicide attempt histories with no recent ideation, clinicians may utilize information on suicide attempt history to facilitate further mental healthcare.
Collapse
Affiliation(s)
- Suzette Glasner
- Digital Therapeutics, Inc., 2443 Fillmore Street, San Francisco, CA, 94115, USA.
- Department of Psychiatry and Biobehavioral Sciences, UCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA.
| | - August X Wei
- Office of the Clinical Director, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
| | - Patrick C Ryan
- Office of the Clinical Director, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
| | - Darcy N Michero
- Digital Therapeutics, Inc., 2443 Fillmore Street, San Francisco, CA, 94115, USA
| | - Laura B Monico
- Digital Therapeutics, Inc., 2443 Fillmore Street, San Francisco, CA, 94115, USA
| | | | - Lisa M Horowitz
- Office of the Clinical Director, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
| |
Collapse
|